Sdi Share Discussion Threads

[hastings] 03/8/2017 09:12

True, particularly applicable to surgical instruments that are already contaminated. Hard to believe that one but apparently a common and increasing problem.

[greyingsurfer] 03/8/2017 08:55

Suffice to say that ProReveal HAS AND IS going to lead to the NHS having to CHANGE ITS METHODS of washing surgical insrtruments

It's not just the NHS, BW, it's everywhere. The potential market is far bigger than the NHS.

Peter

[buywell3] 03/8/2017 07:59

My research has shown that current cleaning methods used within the NHS need to change

Enzymatic cleaning products work best on stainless steel surgical instuments

This was found out by Professor David Perrett PhD CChem FRSC, Professor Emeritus of BioAnalytical Science, Barts & The London School of Medicine, Queen Mary University of London

It was found out when he used ProReveal to ascertain the effectiveness of several different types of traditional cleaning methods many of which are still in use within the NHS


I can put up the link if anyone wants to read through it .... takes a while and is a bit heavy for some probably


Suffice to say that ProReveal HAS AND IS going to lead to the NHS having to CHANGE ITS METHODS of washing surgical insrtruments PLUS it has demonstrated that surgical instruments MUST BE KEPT WET/MOIST after operational use BEFORE AND UP TO putting them through the washing cycle

ProReveal is going to revolutionise the way the NHS tests , uses and washes its surgical instruments

How about them apples


Is the NHS fully aware yet ?









These seminars are taking place



Date

Wednesday 05 July 2017

HTM 01-01 & HTM 01-06: How Compliant Is YOUR Department?

Decontamination seminar -

Last summer the Department of Health published the revised HTM 01-01 guidance on the management and decontamination of reusable surgical instruments and medical devices used in acute care and the HTM 01-06 guidance on the management and decontamination of flexible endoscopes.

Representatives from IHEEM's Decontamination Technical Platform and Authorising Engineer (D) Registration Board will provide delegates with an opportunity to gain key insights into the subject matter, and have open discussions with some of the sector's leading experts, who have been directly involved in shaping the guidance.

This is the third seminar of the series and will enable delegates to identify the main changes to the HTM 01-01 and HTM 01-06 guidance and the implications these have for your estate.



Venue

Cranmore Park, Cranmore Avenue, Shirley, Solihull, West Midlands, B90 4LE



Seminar speakers

Robert Kingston BSc (Hons) CENG MIMECHE MCIBSE MEI FIHEEM FRSH AE(D), Director of KSVAS Ltd and Chair of the IHEEM Decontamination Technical Platform
Graham Stanton IEng FIHEEM AE(D), Retired Senior Decontamination Engineer at NWSSP-SES, Chair of IHEEM AE(D) Registration Board
Sulisti Holmes PhD MIHEEM, Head of Decontamination and Incident Reporting Investigation Centre, Health Facilities Scotland, NHS National Services Scotland
Gary Wright, Commercial Services and Project Manager, STERIS Solutions Ltd
Professor David Perrett PhD CChem FRSC, Professor Emeritus of BioAnalytical Science, Barts & The London School of Medicine, Queen Mary University of London
Matthew Peskett, Managing Director, Peskett Solutions Ltd

[buywell3] 02/8/2017 17:13

One can't knock SDI for this acquisition strategy that they have adopted.
It is paying off very well, Mike Creedon seems to be able to keep on coming up trumps.
Another acquisition coming , and I hope soon , and without any more dilution too.

Very nice

Thank you very much says buywell3



'' Our next purchase will very likely be be executed through using some of our own cash along with taking on some debt”.

Although this may imply a smaller purchase than the previous two, given the board's apparent eye for selecting well and successfully bedding in, then shareholders should be optimistic on any deal that is concluded.

[hastings] 02/8/2017 13:32

Welcome rivaldo.I think to have scored with ten NHS trusts to date is a great result and one would hope and perhaps assume that this will now kick on and grow substantially over the next year as full compliance with DOH guidelines is expected by 2018.There's also the unknown potential from the US of course which could be small up to very substantial along with potential for the Asia Pacific.Bearing in mind we have Sentek, Astles and Atik going well and the prospect of another acquisition then the story is looking as attractive as ever.

[rivaldo] 02/8/2017 12:32

Great info hastings, cheers.

Good to see the ProReveal NHS adoption now featured on SDI's company web site:



"Wednesday 2nd August, 2017

HTM01:01

We are pleased to announce that the ProReveal has been adopted to date by 10 NHS Trusts in the UK to comply with the protein detection requirements of the updated HTM01:01. The ProReveal is not only helping with their compliance - it is also giving them technology, that is helping with their wash process optimisation.

Link to original article"

[hastings] 02/8/2017 08:30

Good spot and welcome news. Particularly given that the competition from Southampton Uni and Edinburgh are apparently 12-18 months away from actually coming to market and likely to be more expensive too then recent wins bode well.

[buywell3] 01/8/2017 16:42

Ha Ha

well done riv .... good to know I am one step ahead of you





















8 steps ahead of the rest though

[rivaldo] 01/8/2017 14:52

Bywell, now that IS an interesting post, cheers. The SDI results said only that Proreveal was "being trialled by NHS hospitals across the UK", with "the sale in 2017 of eight systems to prestigious teaching hospitals". Is this an increase from 8 to 10, or are these 10 additional to the 8?

Whatever, it seems that ProReveal is now gaining good traction.

BTW, I had to search reasonably hard for the proof for your post - here's a link:

[buywell3] 01/8/2017 07:59

''Adoption of the ProReveal Technology to comply with the Protein detection requirements of HTM01:01

Published on July 25, 2017


Matthew Peskett

Peskett Solutions Ltd

I am pleased to announce that the ProReveal has been adopted to date by 10 NHS Trusts in the UK to comply with the protein detection requirements of the updated HTM01:01.

The ProReveal is not only helping with their compliance. It is also giving them technology, that is helping with their wash process optimisation.''

[wilmdav] 31/7/2017 16:07

SDI provides adjusted figures for pre-tax profit, adding back the usual items of acquisition costs, amortisation of acquired intangibles, reorganisation costs and share based payment charges but they do not provide adjusted earnings per share numbers.

I assume FinnCap’s forecasts for 2017-18 incorporate similar adjustments for pre-tax profit and an estimated tax rate to calculated adjusted eps.

I have calculated eps for the last 3 years using adjusted pre-tax profit, normalised tax and weighted average number of shares. The normalised tax rate used is 8%, which is the actual rate for 2017. This is my guess at the rate used by FinnCap for their 2018 forecast. SDI get a reduction in tax for R&D.

. 2015 2016 2017 2018EReported 0.15 1.17 1.17Adjusted 1.33 1.47 1.70 1.9Increase 10.5% 15.6% 11.8%


The 2018 forecast is presumably a rounded figure so could be anything from 1.86 to 1.94. It was first made by FinnCap in January this year (according to Sharepad) so they would not have known the actual 2017 tax rate at the time. There was a small tax credit in the half-year results.

In the unlikely event that Fincap is using 20% tax for its forecast, normalising tax for the prior years at that rate would result in adjusted eps as follows;

. 2015 2016 2017 2018E. 1.15 1.26 1.44 1.9 Increase 9.5% 14.3% 31.9%


Easier to pin down are increases in operating margins over the same period:

. 2015 2016 2017 2018EReported 1.4% 5.9% 9.3%Adjusted 0.5% 9.6% 12.8% 15.9%

[rivaldo] 31/7/2017 11:38

Great article hastings, thx.

A P/E of 13 falling to 11 - with around 10% of the m/cap supported by the cash pile - is pretty decent value anyway. But Proreveal's progress adds a transformational leg to the business given not only initial sales, but more importantly the high margin subsequent recurring income.

Particularly if it takes off in the USA following the sales and trials over there, together with potential from the new European and Asian distributors.

Encouraging to hear that any new acquisition won't require dilution too. Hopefully there's another one on its way soon.

[hastings] 31/7/2017 10:25

Write up on the back of speaking with the company last week.

[buywell3] 28/7/2017 17:28

Let me be frank Frank

If this isn't 40p within 2 years as of today I am losing my touch

If it is as I have sometimes promised .... my nasties will be on display for all to view and they are not a pretty site

What has happened as I think rivaldo might have mentioned as I think hastings was on the phone to the CEO at the time

The earnings per share look to have flat-lined so at a glance the share growth appears to have stalled .... how wrong eh.

Any newbe take note

The number of shares jumped by 23,846,155 shares to acquire Astles control systems in Jan 2017 to 88,840,000

So there used to be only around 65M shares when the 2015 earnings number of 1.17p a share calculation was carried out.

The number of shares now has risen by 36.6% since , revenues are up 26.85% from 8.47m to 10.75m while net income improved 45.01% from 571.00k to 828.00k not too shabby.

Most FTSE250 and FTSE100 stocks would kill for such a rise

Look at these very decent financials



Without a doubt the sale of ProReveal plus the out-performance that is taking place across every division of the company apart from Olympus products (arts infra red cameras)which I read as flat - hence I would like to see that sold and the monies rolled into the next acquisition..... the out-performance coupled with the coming surge of ProReveal units will result in a rise in 2018 forecast revenue of £12.8M to nearer £14M ... a full year of Astles Control Systems also to include




This share is looking a bargain , a safe kind of growth stock in a sweet spot sector

Just get Olympus products sold please

dyor

[frankwhite] 28/7/2017 16:38

Thanks buywell very interesting. I'm heavily invested here so any information is appreciated!

[buywell3] 28/7/2017 11:42

Have I said that I like this or did you guess ?

[hastings] 28/7/2017 07:56

How much do you reckon

[buywell3] 28/7/2017 07:43

Results were to 30th April

How many of the 8 ProReveal units have been sold to the NHS after 30th April ?

IMO ALL EIGHT OF THEM

How much a unit ?

[buywell3] 26/7/2017 12:45

I know ..... but it does NOT have the red ''read more'' button like the rest


Note

Re that the Final Results today:

What can anybody tell me re the date and sales in the last quarter ?

SCIENTIFIC DIGITAL IMAGING PLC

Final Results for the year ended 30 April 2017

[buywell3] 26/7/2017 12:20

Why hasn't the website been updated to include Astles which,acquired 6 months ago ?



It ain't on the list ..................... why not ?

[buywell3] 26/7/2017 10:31

IC = International Comic ...... IMO read by comedians

Look


''Atik Cameras also exceeded its forecast, driven mainly by sales of bespoke and off-the-shelf cameras to OEM customers in the life science sector. Synbiosis has seen good sales growth of its ProtoCOL 3 system in pharmaceutical markets for vaccine and antibiotic testing where the division has added new analysis software.''


''Opus, the camera for the art market, generated good steady sales.''

Sell Opus parlay the cash

Parlay it into another OEM area where we are making GOOD progress and margins are HIGH

And OEM fits with the Scientific Digital Imaging focus ...... not in the art farty world of myopic dreamers



Added:

It is Opus Instruments that I would like to see sold

This is the name SDI have used for the Artworks camera
Artemis Cameras doing great as are Atik

Opus Instruments
Opus Instruments is the manufacturer of the Osiris infrared imaging system designed specifically for art conservators to provide high-resolution, high-speed images in a small portable camera. Osiris has been used to examine hundreds of works of art at many of the major national art galleries throughtout the world. In the Louvre, works by artists such as Leonarado da Vinci, Rembrandt, Watteau have been examined. An ARM(R) microcontroller sits at the heart of the camera controlling the scanning system, driving the infrared sensor and sending the captured data to the PC over a USB connection. The PC receives the data stream and assembles it into an image of the under drawing, displaying it as the scanning process proceeds.

[pj 1] 26/7/2017 10:27

I'm working from memory as I don't (yet)subscribe to IC, but didn't they hint at beating expectations? Hence IC followers selling I'd suspect.